Concepedia

Renée L. DesJarlais

RL

57

Publications

3.4K

Citations

32

H-Index

1986

Active since

Affiliations

Johnson & Johnson (United States)(Current)

New Frontier

Janssen (United States)

Springhouse

Janssen (Belgium)

Renée L. DesJarlais is an author at Johnson & Johnson (United States) specializing in medicine, drug discovery, and pharmacology.

ORCID

Top concepts

Publications per year

1986–2022

57

Publications

57

Using shape complementarity as an initial screen in designing ligands for a receptor binding site of known three-dimensional structure

Renée L. DesJarlais, Robert P. Sheridan, George Seibel et al. · Journal of Medicinal Chemistry · 1988 · 404 citations

Structure-based design of nonpeptide inhibitors specific for the human immunodeficiency virus 1 protease.

Renée L. DesJarlais, George Seibel, Irwin D. Kuntz et al. · Proceedings of the National Academy of Sciences · 1990 · 254 citations · Full text

, , +18

Docking flexible ligands to macromolecular receptors by molecular shape

Renée L. DesJarlais, Robert P. Sheridan, Jonathan S. Dixon et al. · Journal of Medicinal Chemistry · 1986 · 248 citations

, , +11

Current and Future Roles of Artificial Intelligence in Medicinal Chemistry Synthesis

Thomas J. Struble, Juan C. Alvarez, Scott P. Brown et al. · Journal of Medicinal Chemistry · 2020 · 236 citations · Full text

Comparison of Automated Docking Programs as Virtual Screening Tools

Maxwell D. Cummings, Renée L. DesJarlais, Alan C. Gibbs et al. · Journal of Medicinal Chemistry · 2005 · 205 citations

Rows per page

1–5 of 57